Bliss GVS Pharma Ltd

Bliss GVS Pharma Annual General Meeting

Bliss GVS Pharma concluded its 41st AGM on July 15, 2026. Shareholders approved a 100% final dividend of Re. 1.00 per share for FY 2025-26.

Bliss GVS Pharma Other Announcement

Bliss GVS Pharma updated contact details for KMPs authorized to determine and report material events. This administrative update ensures compliance with SEBI LODR Regulation 30(5).

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma allotted ESOP shares, increasing paid-up capital. No monetary value disclosed; share count rose from 106.06M to 106.24M.

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma allotted 1,87,750 shares under its ESOP plan. The share capital increased to Rs. 10,62,43,972 after this allotment.

Value

₹0.19 Cr

Bliss GVS Pharma Management Change

Bliss GVS Pharma appointed Rahul Adakmol as CEO, effective July 15, 2026. Narsimha Shibroor Kamath stepped down as CEO but remains Managing Director.

Bliss GVS Pharma Employee Stock Options

Bliss GVS Pharma allotted 2,67,250 equity shares under its ESOP 2019 to employees. The move increases paid-up capital and aligns employee interests with shareholders.

Bliss GVS Pharma Open Offer: ₹829 Cr

Anupam Rasayan announced a ₹829.03 Crore open offer for Bliss GVS Pharma. The acquirer seeks a 26% stake following a controlling share purchase agreement.

Value

₹829.0 Cr

Bliss GVS Pharma Business Update

Bliss GVS Pharma received a WHO-GMP Inspection Closure Report for its Palghar manufacturing facility. This certification confirms compliance with international quality standards for pharmaceutical manufacturing.

Bliss GVS Pharma Promoter Selling

Promoter Gagan Harsh Sharma sold 2,17,123 shares of Bliss GVS Pharma Limited via the open market. This transaction reduced his individual holding to nil.

Bliss GVS Pharma Open Offer: ₹805.1 Cr

Anupam Rasayan India Limited launched an ₹805.12 Crore open offer to acquire a 26% stake in Bliss GVS Pharma Limited. The offer price is set at ₹299 per share.

Value

₹805.1 Cr

Bliss GVS Pharma Open Offer: ₹829 Cr

Anupam Rasayan India Limited launched an ₹829.03 Crore open offer for Bliss GVS Pharma. The offer follows a 43.30% stake acquisition, aiming for a majority 69.51% holding.

Value

₹829.0 Cr

Execution

10 working days post-closure

Bliss GVS Pharma Other Announcement

Bliss GVS Pharma submitted its Annual Secretarial Compliance Report for FY2026. The report details governance adherence and provides updates on previous regulatory non-compliance matters.

Bliss GVS Pharma Management Change

Mr. Santosh Parab completed his final term as Independent Director on May 25, 2026. This planned leadership change follows statutory term limits for independent directors.

Bliss GVS Pharma Acquisition Worth ₹1,370 Cr

Anupam Rasayan India Limited is acquiring a 43.30% stake in Bliss GVS Pharma for ₹1,369.51 Crore. The deal triggers a mandatory 26% open offer.

Value

₹1,370 Cr

Bliss GVS Pharma Open Offer: ₹829 Cr

Anupam Rasayan launched a ₹829.03 Crore open offer to acquire a 26% stake in Bliss GVS Pharma. This follows a majority acquisition trigger via agreement.

Value

₹829.0 Cr

Execution

10 working days (Tendering Period)

Bliss GVS Pharma Promoter Selling

Promoter Punita Sharma sold 24,962 shares of Bliss GVS Pharma via the open market. This transaction reduces the seller's individual stake to zero.